155 related articles for article (PubMed ID: 27756569)
1. Proteasome activator subunit 3 promotes pancreatic cancer growth via c-Myc-glycolysis signaling axis.
Guo J; Hao J; Jiang H; Jin J; Wu H; Jin Z; Li Z
Cancer Lett; 2017 Feb; 386():161-167. PubMed ID: 27756569
[TBL] [Abstract][Full Text] [Related]
2. The c-Myc-LDHA axis positively regulates aerobic glycolysis and promotes tumor progression in pancreatic cancer.
He TL; Zhang YJ; Jiang H; Li XH; Zhu H; Zheng KL
Med Oncol; 2015 Jul; 32(7):187. PubMed ID: 26021472
[TBL] [Abstract][Full Text] [Related]
3. SATB1 Promotes Pancreatic Cancer Growth and Invasion Depending on MYC Activation.
Chen Z; Li Z; Li W; Zong Y; Zhu Y; Miao Y; Xu Z
Dig Dis Sci; 2015 Nov; 60(11):3304-17. PubMed ID: 26108419
[TBL] [Abstract][Full Text] [Related]
4. β2-adrenergic receptor signaling promotes pancreatic ductal adenocarcinoma (PDAC) progression through facilitating PCBP2-dependent c-myc expression.
Wan C; Gong C; Zhang H; Hua L; Li X; Chen X; Chen Y; Ding X; He S; Cao W; Wang Y; Fan S; Xiao Y; Zhou G; Shen A
Cancer Lett; 2016 Apr; 373(1):67-76. PubMed ID: 26803058
[TBL] [Abstract][Full Text] [Related]
5. PSME3 induces epithelial-mesenchymal transition with inducing the expression of CSC markers and immunosuppression in breast cancer.
Yi Z; Yang D; Liao X; Guo F; Wang Y; Wang X
Exp Cell Res; 2017 Sep; 358(2):87-93. PubMed ID: 28529105
[TBL] [Abstract][Full Text] [Related]
6. Regulation of c-Myc protein stability by proteasome activator REGγ.
Li S; Jiang C; Pan J; Wang X; Jin J; Zhao L; Pan W; Liao G; Cai X; Li X; Xiao J; Jiang J; Wang P
Cell Death Differ; 2015 Jun; 22(6):1000-11. PubMed ID: 25412630
[TBL] [Abstract][Full Text] [Related]
7. PIM1 regulates glycolysis and promotes tumor progression in hepatocellular carcinoma.
Leung CO; Wong CC; Fan DN; Kai AK; Tung EK; Xu IM; Ng IO; Lo RC
Oncotarget; 2015 May; 6(13):10880-92. PubMed ID: 25834102
[TBL] [Abstract][Full Text] [Related]
8. PRMT5 enhances tumorigenicity and glycolysis in pancreatic cancer via the FBW7/cMyc axis.
Qin Y; Hu Q; Xu J; Ji S; Dai W; Liu W; Xu W; Sun Q; Zhang Z; Ni Q; Zhang B; Yu X; Xu X
Cell Commun Signal; 2019 Mar; 17(1):30. PubMed ID: 30922330
[TBL] [Abstract][Full Text] [Related]
9. Bufalin inhibits pancreatic cancer by inducing cell cycle arrest via the c-Myc/NF-κB pathway.
Liu X; Xiao XY; Shou QY; Yan JF; Chen L; Fu HY; Wang JC
J Ethnopharmacol; 2016 Dec; 193():538-545. PubMed ID: 27686271
[TBL] [Abstract][Full Text] [Related]
10. The deubiquitinating enzyme USP17 regulates c-Myc levels and controls cell proliferation and glycolysis.
Nagasaka M; Inoue Y; Yoshida M; Miyajima C; Morishita D; Tokugawa M; Nakamoto H; Sugano M; Ohoka N; Hayashi H
FEBS Lett; 2022 Feb; 596(4):465-478. PubMed ID: 35076962
[TBL] [Abstract][Full Text] [Related]
11. MUC16-mediated activation of mTOR and c-Myc reprograms pancreatic cancer metabolism.
Shukla SK; Gunda V; Abrego J; Haridas D; Mishra A; Souchek J; Chaika NV; Yu F; Sasson AR; Lazenby AJ; Batra SK; Singh PK
Oncotarget; 2015 Aug; 6(22):19118-31. PubMed ID: 26046375
[TBL] [Abstract][Full Text] [Related]
12. The prognosis value of proteasome activator subunit 3 expression in gastric cancer.
Chen ZM; Kai Z; Fang J; Chen Y; Fang YF; Hu SJ
J Physiol Pharmacol; 2022 Jun; 73(3):. PubMed ID: 36515625
[TBL] [Abstract][Full Text] [Related]
13. Fructose-1,6-bisphosphatase is a novel regulator of Wnt/β-Catenin pathway in breast cancer.
Li K; Ying M; Feng D; Du J; Chen S; Dan B; Wang C; Wang Y
Biomed Pharmacother; 2016 Dec; 84():1144-1149. PubMed ID: 27780144
[TBL] [Abstract][Full Text] [Related]
14. PSME3 induces radioresistance and enhances aerobic glycolysis in cervical cancer by regulating PARP1.
Wei X; Sun K; Li S; Lin C; Wei Z
Tissue Cell; 2023 Aug; 83():102151. PubMed ID: 37467687
[TBL] [Abstract][Full Text] [Related]
15. Silencing PSME3 induces colorectal cancer radiosensitivity by downregulating the expression of cyclin B1 and CKD1.
Song W; Guo C; Chen J; Duan S; Hu Y; Zou Y; Chi H; Geng J; Zhou J
Exp Biol Med (Maywood); 2019 Nov; 244(16):1409-1418. PubMed ID: 31630568
[TBL] [Abstract][Full Text] [Related]
16. Gankyrin promotes the proliferation of human pancreatic cancer.
Meng Y; He L; Guo X; Tang S; Zhao X; Du R; Jin J; Bi Q; Li H; Nie Y; Liu J; Fan D
Cancer Lett; 2010 Nov; 297(1):9-17. PubMed ID: 20483533
[TBL] [Abstract][Full Text] [Related]
17. HMGA1 promoting gastric cancer oncogenic and glycolytic phenotypes by regulating c-myc expression.
Cao XP; Cao Y; Zhao H; Yin J; Hou P
Biochem Biophys Res Commun; 2019 Aug; 516(2):457-465. PubMed ID: 31229266
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-184 Deregulated by the MicroRNA-21 Promotes Tumor Malignancy and Poor Outcomes in Non-small Cell Lung Cancer via Targeting CDC25A and c-Myc.
Lin TC; Lin PL; Cheng YW; Wu TC; Chou MC; Chen CY; Lee H
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1532-9. PubMed ID: 25990966
[TBL] [Abstract][Full Text] [Related]
19. OLR1 Promotes Pancreatic Cancer Metastasis via Increased c-Myc Expression and Transcription of HMGA2.
Yang G; Xiong G; Feng M; Zhao F; Qiu J; Liu Y; Cao Z; Wang H; Yang J; You L; Zheng L; Zhang T; Zhao Y
Mol Cancer Res; 2020 May; 18(5):685-697. PubMed ID: 32019809
[TBL] [Abstract][Full Text] [Related]
20. SIRT3 inhibits prostate cancer by destabilizing oncoprotein c-MYC through regulation of the PI3K/Akt pathway.
Quan Y; Wang N; Chen Q; Xu J; Cheng W; Di M; Xia W; Gao WQ
Oncotarget; 2015 Sep; 6(28):26494-507. PubMed ID: 26317998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]